Druggable targets and immunological mechanisms for type 1 diabetes treatment: Genetic evidence from multi‐omics Mendelian randomization combined with meta‐analysis
This study used a Mendelian randomization approach to provide genetic evidence, providing insights and direction for the development of preventive and therapeutic drugs for T1DM.
Authors
- D G Li (ORCID: https://orcid.org/0009-0004-5675-6162)
- Xi Mei (ORCID: https://orcid.org/0009-0007-8557-2479)
- Defeng Wang (ORCID: https://orcid.org/0000-0002-4051-8096)
- Yazhou Li
- Na Wu
- Houjian Ren
- Li Sun
- Min Ge
- Ye Tian
- Baichao Li
Institutions
- Hebei University of Engineering (CN)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-12-21
- DOI
- https://doi.org/10.1111/dme.70176
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00